Your browser doesn't support javascript.
loading
Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.
Melaiu, Ombretta; Macauda, Angelica; Sainz, Juan; Calvetti, Diego; Facioni, Maria Sole; Maccari, Giuseppe; Ter Horst, Rob; Netea, Mihai G; Li, Yang; Grzasko, Norbert; Moreno, Victor; Jurczyszyn, Artur; Jerez, Andrés; Watek, Marzena; Varkonyi, Judit; Garcia-Sanz, Ramon; Kruszewski, Marcin; Dudzinski, Marek; Kadar, Katalin; Jacobsen, Svend Erik Hove; Mazur, Grzegorz; Andersen, Vibeke; Rybicka, Malwina; Zawirska, Daria; Razny, Malgorzata; Zaucha, Jan Maciej; Ostrovsky, Olga; Iskierka-Jazdzewska, Elzbieta; Reis, Rui Manuel; Stepien, Anna; Beider, Katia; Nagler, Arnon; Druzd-Sitek, Agnieszka; Marques, Herlander; Martìnez-Lopez, Joaquin; Lesueur, Fabienne; Avet-Loiseau, Hervé; Vangsted, Annette Juul; Krawczyk-Kulis, Malgorzata; Butrym, Aleksandra; Jamroziak, Krzysztof; Dumontet, Charles; Vogel, Ulla; Rymko, Marcin; Pelosini, Matteo; Subocz, Edyta; Szombath, Gergely; Sarasquete, Maria Eugenia; Silvestri, Roberto; Morani, Federica.
Affiliation
  • Melaiu O; Department of Biology, University of Pisa, Pisa, Italy.
  • Macauda A; Department of Biology, University of Pisa, Pisa, Italy.
  • Sainz J; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Calvetti D; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
  • Facioni MS; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Maccari G; Department of Medicine, University of Granada, Granada, Spain.
  • Ter Horst R; Department of Biology, University of Pisa, Pisa, Italy.
  • Netea MG; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Li Y; Department of Biology, University of Pisa, Pisa, Italy.
  • Grzasko N; The Pirbright Institute, Pirbright, Surrey, UK.
  • Moreno V; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Jurczyszyn A; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Jerez A; Department for Immunology and Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.
  • Watek M; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Varkonyi J; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Garcia-Sanz R; Hematology Department, St. John's Cancer, Lublin, Poland.
  • Kruszewski M; Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona. Hospitalet de Llobregat, Barcelona, Spain.
  • Dudzinski M; Department of Hematology, Cracow University Hospital, Cracow, Poland.
  • Kadar K; Hematology and Medical Oncology Department, University Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Jacobsen SEH; Holycross Medical Center, Kielce, Poland.
  • Mazur G; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Andersen V; Department of Hematology, University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca, IBSAL, Salamanca, Spain.
  • Rybicka M; Department of Hematology, University Hospital, Bydgoszcz, Poland.
  • Zawirska D; Department of Hematology, Specialist District Hospital, Rzeszow, Poland.
  • Razny M; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Zaucha JM; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg, Denmark.
  • Ostrovsky O; Department of Internal Diseases, Hypertension and Occupational Medicine, Medical University, Wroclaw, Poland.
  • Iskierka-Jazdzewska E; Research Unit of Molecular Diagnostics and Clinical Research, Laboratory Center, Hospital of Southern Jutland, Aabenraa, Denmark.
  • Reis RM; Institute of Regional Health Research, and Institute of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Stepien A; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
  • Beider K; Department of Hematology, Cracow University Hospital, Cracow, Poland.
  • Nagler A; Department of Hematology, Rydygier Hospital, Cracow, Poland.
  • Druzd-Sitek A; Department of Hematology, Sea Hospital, Gdynia, Poland.
  • Marques H; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Martìnez-Lopez J; Department of Hematology, Medical University of Lodz, Lodz, Poland.
  • Lesueur F; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
  • Avet-Loiseau H; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Vangsted AJ; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Krawczyk-Kulis M; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Lodz, Poland.
  • Butrym A; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Jamroziak K; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Dumontet C; Department of Lymphoid Malignancies, Maria Sklodowska-Curie Memorial Institute and Oncology Centre Warsaw, Warsaw, Poland.
  • Vogel U; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
  • Rymko M; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Pelosini M; Department of Hematology, Hospital Universitario 12 de Octubre, Complutense School of Medicine, CNIO, Madrid, Spain.
  • Subocz E; Institut Curie, Paris, France.
  • Szombath G; PSL Research University, Paris, France.
  • Sarasquete ME; Inserm, Paris, France.
  • Silvestri R; Mines Paris Tech, Fontainebleau, France.
  • Morani F; Hematology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Int J Cancer ; 148(8): 1887-1894, 2021 04 15.
Article in En | MEDLINE | ID: mdl-33152124
ABSTRACT
We evaluated the association between germline genetic variants located within the 3'-untranlsated region (polymorphic 3'UTR, ie, p3UTR) of candidate genes involved in multiple myeloma (MM). We performed a case-control study within the International Multiple Myeloma rESEarch (IMMEnSE) consortium, consisting of 3056 MM patients and 1960 controls recruited from eight countries. We selected p3UTR of six genes known to act in different pathways relevant in MM pathogenesis, namely KRAS (rs12587 and rs7973623), VEGFA (rs10434), SPP1 (rs1126772), IRF4 (rs12211228) and IL10 (rs3024496). We found that IL10-rs3024496 was associated with increased risk of developing MM and with a worse overall survival of MM patients. The variant allele was assayed in a vector expressing eGFP chimerized with the IL10 3'-UTR and it was found functionally active following transfection in human myeloma cells. In this experiment, the A-allele caused a lower expression of the reporter gene and this was also in agreement with the in vivo expression of mRNA measured in whole blood as reported in the GTEx portal. Overall, these data are suggestive of an effect of the IL10-rs3024496 SNP on the regulation of IL10 mRNA expression and it could have clinical implications for better characterization of MM patients in terms of prognosis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Germ-Line Mutation / Genetic Predisposition to Disease / 3' Untranslated Regions / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2021 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Germ-Line Mutation / Genetic Predisposition to Disease / 3' Untranslated Regions / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2021 Type: Article Affiliation country: Italy